Biochemical, molecular and preclinical characterization of a double-virus-reduced human butyrylcholinesterase preparation designed for clinical use.
Weber
A
A
Baxter BioScience, Vienna, Austria.
Butterweck
H
H
Mais-Paul
U
U
Teschner
W
W
Lei
L
L
Muchitsch
E-M
EM
Kolarich
D
D
Altmann
F
F
Ehrlich
H J
HJ
Schwarz
H P
HP